Ascension-Q raises £250k in pre-seed funding led by Jenson Funding Partners to expand clinical trial software.
The pre-seed round was led by Jenson Funding Partners to help expand clinical trial software across UK and Irish hospitals.
Ascension-Q provides a cloud-based clinical research operating system designed to streamline trials for hospital research teams and improve patient recruitment.
Ascension-Q has secured £250k in a pre-seed investment led by Jenson Funding Partners. The startup intends to direct the capital towards expanding its clinical trial platform across hospitals and clinics in the UK and Ireland.
Founded in 2020, the company provides a cloud-based operating system designed to assist research teams with participant recruitment, retention, and study management. The platform is currently deployed across 16 hospitals and has supported 70 clinical trials.
From the founder
"We are delighted in raising investment from Jenson Funding Partners and continuing our incredible journey with their support. AscensionQ was created to tackle the everyday challenges researchers face through automation in one platform, connecting people and not just processes. It has been fantastic working with the research community to create ‘a first of its kind’ research clinic operating system. From well-established research institutions through to newer organisations, the AQ platform has shown to increase clinical trial capacity for hospitals, improve patient recruitment and retention and support the business opportunity that research presents for NHS trusts. Our ‘buy-once, use many’ philosophy has enabled our customers to do more with less. 2022 was great validation of our system and for 2023 we are excited to push on and help the thousands of research clinics in the UK and beyond."
Amitava Ganguli
Founder and CEO at Ascension-Q
Investor perspective
"The drug development industry is so critical to the health of the global population. Ascension-Q is changing the game for clinical trials by really focusing on the staff and researchers who are working on making the life-changing discoveries of new drugs and treatments. It is inspiring to see a difficult clinical trial process become far more seamless from start to finish with a complete overview throughout. We’re honoured to be investing in a company that’s working to be at the forefront of innovation in this space and with the potential to improve the lives of patients around the world."
Sarah Barber
CEO, Jenson Funding Partners
Investors
Categories
About the company
Ascension-Q
A clinical research operating system that helps researchers run trials more efficiently.